BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 31605172)

  • 1. Does the ATA Risk Stratification Apply to Patients with Papillary Thyroid Microcarcinoma?
    Stefanova DI; Bose A; Ullmann TM; Limberg JN; Finnerty BM; Zarnegar R; Fahey TJ; Beninato T
    World J Surg; 2020 Feb; 44(2):452-460. PubMed ID: 31605172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATA risk stratification in papillary thyroid microcarcinoma has low positive predictive value when identifying recurrence.
    Tran A; Weigel RJ; Beck AC
    Am J Surg; 2024 Mar; 229():106-110. PubMed ID: 37968147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of Thyroid Microcarcinoma in Patients Who Underwent Total Thyroidectomy with Benign Indication-A 5-Year Retrospective Review.
    Magra V; Boulogeorgou K; Paschou E; Sevva C; Manaki V; Mpotani I; Mantalovas S; Laskou S; Kesisoglou I; Koletsa T; Sapalidis K
    Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541194
    [No Abstract]   [Full Text] [Related]  

  • 4. The overtreatment of papillary thyroid microcarcinoma in the community.
    Abraham PJ; Wu C; Wang R; Herring B; Zmijewski P; Gillis A; Fazendin J; Lindeman B; Chen H
    Am J Surg; 2024 Jul; 233():132-135. PubMed ID: 38462410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papillary Thyroid Microcarcinoma: Differences between Lesions in Incidental and Nonincidental Settings-Considerations on These Clinical Entities and Personal Experience.
    Lucandri G; Fiori G; Falbo F; Pende V; Farina M; Mazzocchi P; Santonati A; Bosco D; Spada A; Santoro E
    Curr Oncol; 2024 Feb; 31(2):941-951. PubMed ID: 38392064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality rate and causes of death in papillary thyroid microcarcinoma.
    Heo J; Ryu HJ; Park H; Kim TH; Kim SW; Oh YL; Chung JH
    Endocrine; 2024 Mar; 83(3):671-680. PubMed ID: 37814113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The survival after thyroidectomy versus lobectomy in multifocal papillary thyroid microcarcinoma patients.
    Ai X; Zhang K; Xu J; Xiao H; Li L; Sun P; Li J
    Endocrine; 2024 Apr; ():. PubMed ID: 38622433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial ablation ratio predicts the recurrence of low-risk papillary thyroid microcarcinomas treated with microwave ablation: a 5-year, single-institution cohort study.
    Ren Y; Han X; Li Y; Chen G; Jiang L; Liu C; Xu S
    Endocr Connect; 2023 Aug; 12(9):. PubMed ID: 37467003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival benefits of extensive surgery in patients with papillary thyroid microcarcinoma.
    Herrera M; Hussein MH; Persons E; Alias MR; Rabee A; Sayed A; Toraih E; Kandil E
    Am J Surg; 2024 Mar; 229():99-105. PubMed ID: 37989608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical factors for choosing active surveillance: an analysis of papillary thyroid microcarcinoma patients with recurrence.
    Won HR; Kim MG; Kim MS; Chang JW; Koo BS
    Eur Thyroid J; 2023 Dec; 12(6):. PubMed ID: 37992297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choice of management strategy for papillary thyroid microcarcinoma: active surveillance or immediate surgery?
    Liu Q; Song M; Zhang H
    J Cancer; 2024; 15(4):1009-1020. PubMed ID: 38230222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active surveillance for adult low-risk papillary thyroid microcarcinoma-a review focused on the 30-year experience of Kuma Hospital.
    Ito Y; Miyauchi A; Fujishima M; Yamamoto M; Sasaki T
    Endocr J; 2024 Jan; 71(1):7-21. PubMed ID: 37793883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative Serum Thyroglobulin Levels Predict Radioiodine Therapy Outcome in Papillary Thyroid Microcarcinoma Patients.
    Cheng X; Fan Y; Ye W; Xu S; Wu J; Gao W; Bao J; Yu H; Zhang L
    Horm Metab Res; 2024 Apr; ():. PubMed ID: 38503312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative risk stratification for patients with ≤ 1 cm papillary thyroid carcinomas based on preoperative blood inflammatory markers: construction of a dynamic predictive model.
    Zhao L; Hu T; Cai Y; Zhou T; Zhang W; Wu F; Zhang Y; Luo D
    Front Endocrinol (Lausanne); 2023; 14():1254124. PubMed ID: 38189045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The American Thyroid Association risk stratification and long-term outcomes of differentiated thyroid cancer: a 20-year follow-up of patients in Saudi Arabia.
    Jammah AA; AlSadhan IM; Alyusuf EY; Alajmi M; Alhamoudi A; Al-Sofiani ME
    Front Endocrinol (Lausanne); 2023; 14():1256232. PubMed ID: 38047113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is unicentric familial papillary thyroid microcarcinoma different from multicentric?
    Ríos A; Ruiz-Pardo J; Balaguer-Román A; Puñal JA; Moreno P; Mercader E; Ferrero E; Morlán MA; Martín J; Durán M; Bravo JM; Casanova D; Salvador-Egea MP; Torregrosa NM; Exposito-Rodríguez A; Martínez-Fernández G; Carrión AM; Vidal O; Herrera F; Ruiz-Merino G; Rodríguez JM
    Endocrine; 2023 Dec; 82(3):613-621. PubMed ID: 37490266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study.
    Ríos A; Rodríguez MA; Puñal JA; Moreno P; Mercader E; Ferrero E; Ruiz-Pardo J; Morlán MA; Martín J; Durán-Poveda M; Bravo JM; Casanova D; Egea MPS; Torregrosa NM; Exposito-Rodríguez A; Martínez-Fernández G; Carrión AM; Vidal O; Herrera F; Ruiz-Merino G; Rodríguez JM
    Langenbecks Arch Surg; 2022 Dec; 407(8):3631-3642. PubMed ID: 36251077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total tumor diameter is a better indicator of multifocal papillary thyroid microcarcinoma: A propensity score matching analysis.
    Jiang KC; Lin B; Zhang Y; Zhao LQ; Luo DC
    Front Endocrinol (Lausanne); 2022; 13():974755. PubMed ID: 36004348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk-stratified papillary thyroid microcarcinoma: post-operative management and treatment outcome in a single center.
    Kanokwongnuwat W; Larbcharoensub N; Sriphrapradang C; Suppasilp C; Thamnirat K; Sakulpisuti C; Kositwattanarerk A; Utamakul C; Sritara C; Chamroonrat W
    Endocrine; 2022 Jun; 77(1):134-142. PubMed ID: 35476179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of Contrast-Enhanced Ultrasound in the Preoperative Evaluation of Papillary Thyroid Carcinoma Invasiveness.
    Chen L; Chen L; Liang Z; Shao Y; Sun X; Liu J
    Front Oncol; 2021; 11():795302. PubMed ID: 35096595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.